The INTERLACE phase III trial assessed whether a short course of induction chemotherapy (IC) prior to chemoradiation (CRT) could reduce the rate of relapse and death among patients with locally ...
Add Yahoo as a preferred source to see more of our stories on Google. The new regime is a short course of chemotherapy followed by chemoradiation (a combination of chemotherapy and radiotherapy).
Share on Pinterest Results from a phase 3 clinical trial show promise for a new standard of care for treating people with advanced cervical cancer. AzmanL/Getty Images A phase 3 clinical trial ...
The INTERLACE phase III trial, funded by Cancer Research UK and UCL Cancer Trials Centre, assessed whether a short course of induction chemotherapy (IC) prior to chemoradiation (CRT) could reduce the ...
A short course of chemotherapy followed by chemoradiotherapy significantly improved progression-free survival and overall survival in women with locally advanced cervical cancer, according to a ...
Cervical cancer patients were significantly more likely to be alive and cancer-free after five years when given a short course of chemotherapy prior to chemoradiation, finds a clinical trial led by ...
The INTERLACE phase III trial, funded by Cancer Research UK and UCL Cancer Trials Centre, assessed whether a short course of induction chemotherapy (IC) prior to chemoradiation (CRT) could reduce the ...
The researchers are interested in how future studies can investigate the use of immunotherapies to further improve survival rates. Clinicians are hopeful the new approach will give people with ...
A course of treatment with existing drugs prior to chemo-radiation led to a 35% reduction in the risk of death or return of cancer. The INTERLACE phase III trial, funded by Cancer Research UK and UCL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results